Labiotech.eu

Springwave spirulina algae microalgae biotech drink hong kong facebook drink algama

News and Trends 31 May 2016

Asian Super investor claims stake in Microalgae Drink Startup

The French startup Algama has received €3.5M investment from the Hong Kong billionaire, Li Ka-shing, known for his stakes in Facebook, Spotify, and Skype. Based on a microalgae brew, Algama’s nutritional drinks product SpringWave is evidently hitting the marketing mark, by making the algae Spirulina a tasty. But there are many other algae-based products which look to compete in this Omega-3 and […]

May 31, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 31 May 2016

DBV Technologies: “This is our First and most Significant Partnership signed”

The billion-euro Biotech from Paris DBV Technologies just signed a €100M deal with Nestlé Health Science to develop a new diagnostic test of Milk allergies. This is the first deal of DBV and shows the potential of its technological platform. I had a chat with its COO David Schilansky to find out more… DBV is […]

May 31, 2016 - 4 minutesmins - By Philip Hemme

roche diabetes senseonics fluorescent sensor

News and Trends 30 May 2016

Roche debuts new MedTech for needle-free management of Diabetes

Roche is making progress in its Diabetes Care unit. It has struck a deal with the MedTech company Senseonics to sell an implantable glucose sensor in some major European countries. The Diabetes Care division of Swiss big Pharma Roche has more than 35 years of experience, and its Accu-Check devices are one of best-selling diabetes management […]

May 30, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 30 May 2016

Besides Techno, Berlin is also the place to be for Life Science Industries

On the 25th of May, the largest network event for life sciences and healthcare industries in the German capital region once again came to life for the 14th time, for Bionnale 2016 . As we too belong to this city, we are pleased to summarise the highlights of what happened there… This free event, which belongs to the Life Science’s […]

May 30, 2016 - 3 minutesmins - By Jerome Topsent

carbios bioplastic bio recycling biodegradation

News and Trends 30 May 2016

French Biodegradable Plastics get 2 new key US Patents

Carbios has been granted two key US patents: One for a novel plastic-degrading microorganism, and another for the creation of plastics with a customised lifespan – which could help bioplastics break into more industrial applications. A Green Chemistry company from the French region of Auvergne, Carbios was founded in 2011 but already has had some major […]

May 30, 2016 - 3 minutesmins - By Denise Neves Gameiro

nasdaq merus biotech ipo closing immunooncology cancer breast ovarian colorectal finance

News and Trends 30 May 2016

Dutch Immuno-Oncology Biotech closes massive IPO on the NASDAQ

The Utrecht based Merus has snagged around $47.3M (€42.5M) in an IPO on the NASDAQ market for its portfolio of antibodies targeting breast and colorectal cancers. Back in April 2015, Merus announced its intention to go public on the Nasdaq, with the goal of raising at least €100M for the rest of the year, but […]

May 30, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 28 May 2016

What Happened this Week? Refresh, Virtual Biotech, Bayer and Monsanto

1. So that was Labiotech Refresh! Here are the conference Highlights 2. To Be – or Not To Be, a Virtual Biotech? 3. Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased… 4. Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex 5. French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup […]

May 28, 2016 - 1 minutemin - By Philip Hemme

blood cancer disease model, multi-omics, CAR-T, oncology

News and Trends 28 May 2016

It’s Blood Cancer Day, how is Biotech fixing it?

Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need of better therapies to treat these cancers – which are still often deadly. Blood cancers can affect different type of cells in the blood. Because these cells are so close to the circulatory and immune system, […]

May 28, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 27 May 2016

Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease

The Scandinavian charm is wonderful but this week we are (finally) heading back to Central Europe. Do I really need to say what happens in Paris? We all know that: The Eiffel Tower, the Louvre, the pretty sights, la Seine and it’s also the cité de l’amour. However, it is also where Pharnext, our Biotech of the Week, is […]

May 27, 2016 - 2 minutesmins - By Joachim Eeckhout

labiotech refresh startup conference may berlin biotech startup highlights

News and Trends 27 May 2016

So that was Labiotech Refresh! Here are the conference Highlights

So after months of planning our first biotech conference, it’s kind of surreal to think it’s actually over. For now, anyway! Here’s a recap of the day; speakers, panels, audience and the team, as we put together the premier of Labiotech’s Conference series – Labiotech Refresh. Philip and Joachim during the opening speech. It all kicked […]

May 27, 2016 - 5 minutesmins - By Dani Bancroft

qiagen therawis diagnostics chemotherapy tnbc

News and Trends 26 May 2016

Qiagen partners up for Novel Diagnostic against Breast Cancer

Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective an aggressive chemotherapy will be in patients with high risk breast cancer. A giant in molecular diagnostics, Qiagen is now working in a new diagnostic test that could help guide the treatment of breast cancer. Now, Qiagen has partnered with […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 26 May 2016

French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup

TxCell is restarting its trial for Ovasave, an autologous T-cell therapy, with a new manufacturing partner. This therapy is targeting Crohn’s disease which does not respond to current treatments. TxCell is based in Sophia-Antipolis (France) and is developing immunotherapies based on a type of T-cells that have anti-inflammatory properties – regulatory T-lymphocytes (Tregs). Its most advanced programme is in refractory Crohn’s […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

Resources

Categories

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Approaches

Therapeutic areas

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Asian Super investor claims stake in Microalgae Drink Startup

DBV Technologies: “This is our First and most Significant Partnership signed”

Roche debuts new MedTech for needle-free management of Diabetes

Besides Techno, Berlin is also the place to be for Life Science Industries

French Biodegradable Plastics get 2 new key US Patents

Dutch Immuno-Oncology Biotech closes massive IPO on the NASDAQ

What Happened this Week? Refresh, Virtual Biotech, Bayer and Monsanto

It’s Blood Cancer Day, how is Biotech fixing it?

Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease

So that was Labiotech Refresh! Here are the conference Highlights

Qiagen partners up for Novel Diagnostic against Breast Cancer

French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup

Subscribe to our newsletter to get the latest biotech news!